Table 3 Crude and multivariable-adjusted odds ratios (OR) and 95% confidence intervals (CIs) for novel anthropometric indices and novel risk factors for cardiovascular disease across PDI, hPDI, and uPDI tertiles (n = 490).

From: Plant-based diet indices in relation to novel cardiovascular risk factors, major adverse cardiovascular events, and novel anthropometric indices in patients with type 2 diabetes

Variable

PDI tertiles

hPDI tertiles

uPDI tertiles

 

T1

(n = 187)

T2

(n = 98)

T3

(n = 205)

P-trend*

T1

(n = 195)

T2

(n = 100)

T3

(n = 195)

P-trend*

T1

(n = 196)

T2

(n = 97)

T3

(n = 187)

P-trend*

Novel anthropometric indices

ABSI

Crude1

1

1.24

(0.66–1.89)

0.89

(0.59–1.36)

0.616

1

1.24

(0.66–1.89)

0.89

(0.59–1.36)

0.616

1

1.47

(0.87–2.48)

1.43

(0.94–2.19)

0.087

Model I

1

1.26

(0.74–1.16)

1.27

(0.77–2.12)

0.331

1

1.26

(0.74–1.16)

1.27

(0.77–2.12)

0.331

1

1.35

(0.79–2.29)

1.21

(0.77–1.92)

0.387

Model II

1

1.35

(0.76–2.40)

1.63

(0.91–2.88)

0.092

1

1.35

(0.76–2.40)

1.63

(0.91–2.88)

0.092

1

1.49

(0.86–2.58)

1.25

(0.78–2.01)

0.330

BRI

Crude1

1

0.66

(0.39–1.12)

0.73

(0.47–1.12)

0.165

1

0.60

(0.35–1.03)

0.43

(0.28–0.66)

< 0.001

1

1.50

(0.98–2.53)

1.47

(0.96–2.23)

0.069

Model I

1

0.71

(0.42–1.21)

0.77

(0.50–1.18)

0.251

1

0.62

(0.36–1.07)

0.47

(0.28–0.79)

0.005

1

1.36

(0.80–2.32)

1.2

(0.77–1.92)

0.379

Model II

1

0.85

(0.47–1.51)

0.98

(0.60–1.59)

0.950

1

0.60

(0.33–1.08)

0.61

(0.33–1.11)

0.105

1

1.59

(0.90–2.82)

1.35

(0.82–2.21)

0.224

AVI

Crude1

1

1.15

(0.68–1.94)

0.98

(0.64–1.48)

0.914

1

0.65

(0.39–109)

0.69

(0.45–1.06)

0.093

1

1.19

(0.71–1.99)

1.34

(0.88–2.05)

0.164

Model I

1

1.15

(0.68–1.96)

0.98

(0.64–1.49)

0.917

1

0.63

(0.37–1.06)

0.60

(0.36–1.00)

0.049

1

1.22

(0.72–2.06)

1.41

(0.89–2.27)

0.138

Model II

1

1.37

(0.78–2.42)

1.25

(0.79–1.97)

0.342

1

0.67

(0.39–1.17)

0.85

(0.48–1.51)

0.547

1

1.38

(0.80–2.36)

1.64

(1.01–2.65)

0.042

Novel risk factors for cardiovascular disease

AIP

            

Crude1

1

1.04

(0.62–1.76)

0.98

(0.64–1.48)

0.920

1

0.85

(0.51–1.41)

1.10

(0.72–1.68)

0.643

1

0.93

(0.55–1.57)

0.69

(0.45–1.05)

0.088

Model I

1

1.01

(0.60–1.71)

0.95

(0.62–1.46)

0.842

1

0.82

(0.49–1.37)

0.98

(0.59–1.64)

0.922

1

0.94

(0.55–1.61)

0.71

(0.45–1.13)

0.150

Model II

1

1.01

(0.58–1.76)

0.79

(0.50–1.24)

0.316

1

0.64

(0.37–1.10)

0.74

(0.41–1.32)

0.269

1

0.92

(0.53–1.58)

0.69

(0.43–1.11)

0.128

LAP

            

Crude1

1

0.88

(0.52–1.49)

0.83

(0.54–1.26)

0.390

1

0.48

(0.28–0.80)

0.63

(0.41–0.98)

0.046

1

1.41

(0.83–2.37)

1.31

(0.86–1.99)

0.199

Model I

1

0.88

(0.52–1.49)

0.83

(0.54–1.26)

0.391

1

0.45

(0.27–0.76)

0.54

(0.32–0.92)

0.019

1

1.44

(0.85–2.45)

1.37

(0.87–2.15)

0.172

Model II

1

0.91

(0.52–1.58)

0.86

(0.54–1.36)

0.526

1

0.32

(0.21–0.65)

0.60

(0.33–1.07)

0.064

1

1.48

(0.86–2.55)

1.53

(0.95–2.46)

0.075

CRI 1

            

Crude1

1

1.59

(0.942–2.75)

1.00

(0.66–1.52)

0.999

1

0.87

(0.52–1.45)

0.96

(0.63–1.46)

0.858

1

0.52

(0.31–0.86)

0.76

(0.50–1.18)

0.239

Model I

1

1.58

(0.91–2.73)

1.00

(0.66–1.52)

0.970

1

0.85

(0.50–1.43)

0.89

(0.54–1.48)

0.651

1

0.51

(0.30–0.86)

0.75

(0.47–1.20)

0.261

Model II

1

1.71

(0.95–3.08)

0.80

(0.51–1.26)

0.351

1

0.66

(0.38–1.14)

0.67

(0.37–1.20)

0.160

1

0.50

(0.29–0.85)

0.73

(0.45–1.18)

0.212

CRI 2

            

Crude1

1

1.20

(0.71–2.05)

0.95

(0.63–1.45)

0.829

1

0.81

(0.48–1.35)

0.83

(0.54–1.27)

0.411

1

0.48

(0.29–0.80)

0.74

(0.48–1.15)

0.199

Model I

1

1.16

(0.68–1.98)

0.93

(0.61–1.42)

0.729

1

0.73

(0.43–1.24)

0.61

(0.36–1.03)

0.065

1

0.50

(0.30 − 0.84)

0.80

(0.50–1.28)

0.391

Model II

1

1.20

(0.68–2.10)

0.78

(0.50–1.23)

0.300

1

0.57

(0.33–1.00)

0.43

(0.23–0.76)

0.004

1

0.49

(0.29–0.84)

0.80

(0.49–1.29)

0.388

CI

            

Crude1

1

1.30

(0.76–2.21)

1.02

(0.67–1.55)

0.922

1

0.77

(0.46–1.29)

0.72

(0.59–1.21)

0.298

1

0.49

(0.29–0.82)

0.73

(0.47–1.12)

0.163

Model I

1

1.24

(0.72–2.13)

0.99

(0.65–1.51)

0.950

1

0.68

(0.40–1.15)

0.54

(0.32–0.91)

0.020

1

0.52

(0.31–0.87)

0.80

(0.50–1.28)

0.396

Model II

1

1.26

(0.72–2.21)

0.92

(0.58–1.44)

0.719

1

0.065

(0.32–0.97)

0.42

(0.23–0.76)

0.004

1

0.52

(0.30–0.88)

0.84

(0.52–1.36)

0.507

  1. AIP: Atherogenic index of plasma, CRI 1:Castelli risk index 1, CRI 2: Castelli risk index 2, LAP: lipid accumulation product, CI: (CHOLINDEX), ABSI, a body shape index; BRI, body roundness index; AVI, abdominal volume index.
  2. *Calculated by logistic regression.
  3. 1Unadjusted model.
  4. Model I: adjusted for energy, age, and gender.
  5. Model II: adjusted for energy, age, gender, smoking, socioeconomic status, chronic disease history, having diabetic diets, education, marital status, physical activity, and supplement use.
Back to article page